Rating History for Crescent Biopharma Inc (CBIO) by H.C. Wainwright

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/1/2026 Mitchell S. Kapoor Downgrade Neutral
(Buy)
N/A
(N/A)
20.65
(17.48)
-15.35% Details